Jobs / United States / Astrazeneca Pharmaceuticals Lp
Global Senior Commercial Director, Hematology
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Gaithersburg - MD
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles1 certified filing for “Global Product Teams Finance Director, R&D Finance” (Financial Managers) in MD: $196k–$196k, median $196k. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
The Global Commercial Director, Hematology – Customer Engagement & Advocacy is a key member of the Global Hematology leadership and commercial teams, accountable for shaping and advancing the Franchise Customer Engagement and Advocacy strategy across the Hematology portfolio. The role leads a therapeutic-area and portfolio approach across CLL, NHL and Multiple Myeloma , spanning established brands, emerging assets and early pipeline, and evolves Customer Engagement from individual brand initiatives toward an integrated Franchise model. The role is accountable for building strong external partnerships, developing impactful Advocacy strategies, transforming the customer experience through a OneAZ approach , and leveraging major scientific and external engagement opportunities to strengthen AZ's leadership and generate actionable insights. The role also leads the Advocacy capability , establishing the frameworks, tools and ways of working required to scale effective Customer Engagement across Global, Regions and Markets. Reporting to the Global Hematology Franchise , the role works closely with Commercial, Medical, R&D, Insights & Analytics, Market Access, Communications, Regions and Markets to deliver strategic and measurable impact across the Hematology portfolio. Typical Accountabilities | Job Responsibilities Lead Global Hematology Customer Engagement Strategy • Define and evolve the Franchise-wide Customer Engagement strategy across CLL, NHL and Multiple Myeloma, spanning current and future portfolio priorities. • Translate therapeutic area and portfolio priorities into differentiated Customer Engagement strategies , balancing global consistency with local relevance. • Establish clear priorities, governance and ways of working across Global, Regions and Markets. • Generate and translate customer insights into actionable inputs for Franchise, therapeutic area, brand and development strategies. • Ensure strong integration across Commercial, Medical, R&D, Insights & Analytics and Market Access. Lead Global Hematology Advocacy Strategy & Impact • Define and lead the Hematology Franchise Advocacy strategy , in partnership with Regions and Markets. • Translate strategic priorities into clear Advocacy objectives . • Lead KEE mapping, segmentation and prioritization, including identification of priority experts and emerging leaders. • Support development of market and individual KEE engagement plans, with clear objectives , actions and desired outcomes. • Define and track Advocacy KPIs and impact measures , using insights and performance to refine priorities and plans. • Leverage Advocacy and KEE engagement to strengthen strategy, generate insights and build AZ as a preferred partner in Hematology . Transform the Hematology Customer Experience • Enable a OneAZ approach that provides customers with a consistent , coordinated and differentiated experience across AZ stakeholders. • Establish seamless cross-functional ways of working that remove barriers to effective customer collaboration. • Improve prioritization, coordination and transparency of customer engagement across Global, Regions and Markets. • Deploy tools, platforms and processes that enable a personalized and differentiated customer experience . Lead Strategic External Engagement & Global Congress Strategy • Define and lead the global Hematology strategy for major scientific congresses and strategic external engagement moments. • Turn key scientific meetings into high-impact opportunities for scientific engagement, thought